Endocrinology
News
Don’t discontinue osteoporosis meds for COVID-19 vaccines, expert guidance says
Recommendations help physicians distinguish between a reaction to the vaccine and a reaction to medication.
News
Bone loss common in kidney stone patients, yet rarely detected
Almost one-quarter of patients diagnosed with kidney stones have osteoporosis or a fracture history on diagnosis, yet few undergo bone mineral...
News
How to convince patients muscle pain isn’t a statin Achilles heel: StatinWISE
The strategy seemed to work in this trial: two-thirds of patients who previously rejected statins, perceiving them as the cause of muscle pain,...
News
Large study finds trans men on testosterone at risk for blood clots
Transgender men who take testosterone are at risk of developing erythrocytosis and future thrombotic events, especially if they smoke and are...
News
More from DAPA-HF: Dapagliflozin quickly reduces heart failure events
Conference Coverage
Romosozumab may not increase cardiovascular risk after all
Could a cardioprotective effect of bisphosphonates in a pivotal clinical trial of romosozumab explain why the biologic was given a black-box...
News
Cumulative exposure to high-potency topical steroid doses drives osteoporosis fractures
"A 3% increase in the relative risk of osteoporosis and MOF was observed per doubling of the TCS dose."
News
FDA approves orphan drug evinacumab-dgnb for homozygous FH
Indicated for homozygous familial hypercholesterolemia on top of other lipid-modifying therapy, Evkeeza (Regeneron) is a first-in-class inhibitor...
News
Lifestyle coaching for obesity associated with improved cardiometabolic numbers in study
Experts address funding barriers to patients receiving this type of intervention.
News
A third discontinuing levothyroxine have normal thyroid levels
Those with overt hypothyroidism are less likely to remain euthyroid than patients with subclinical disease, but many wind up restarting treatment...